☰ Navigation Tabs
Structure of the Tandem MA-3 Region of Pdcd4
NMR Experiment Experiment Type Sample Contents Solvent Ionic Strength pH Pressure Temperature (K) Spectrometer 1 3D CBCA(CO)NH 0.15-0.5mM [U-99% 13C; U-99% 15N] Pdcd4 MA-3 M-C; 25mM sodium phosphate; 100mM sodium chloride; 2.5mM DTT; 2.5mM TCEP; 0.05mM EDTA; 0.2mM AEBSF Protease Inhibitor; 0.02% sodium azide; 95% H2O/5% D2O 95% H2O/5% D2O 150 6.5 ambient 308 2 3D HNCO 0.15-0.5mM [U-99% 13C; U-99% 15N] Pdcd4 MA-3 M-C; 25mM sodium phosphate; 100mM sodium chloride; 2.5mM DTT; 2.5mM TCEP; 0.05mM EDTA; 0.2mM AEBSF Protease Inhibitor; 0.02% sodium azide; 95% H2O/5% D2O 95% H2O/5% D2O 150 6.5 ambient 308 3 2D 1H-15N HSQC 0.5mM [U-99% 13C; U-99% 15N] Pdcd4 MA-3 M-C; 25mM sodium phosphate; 100mM sodium chloride; 2.5mM DTT; 2.5mM TCEP; 0.05mM EDTA; 0.2mM AEBSF Protease Inhibitor; 0.02% sodium azide; 95% H2O/5% D2O 95% H2O/5% D2O 150 6.5 ambient 308 4 3D 1H-15N NOESY-HSQC 0.5mM [U-99% 13C; U-99% 15N] Pdcd4 MA-3 M-C; 25mM sodium phosphate; 100mM sodium chloride; 2.5mM DTT; 2.5mM TCEP; 0.05mM EDTA; 0.2mM AEBSF Protease Inhibitor; 0.02% sodium azide; 95% H2O/5% D2O 95% H2O/5% D2O 150 6.5 ambient 308 5 3D TROSY HN(CO)CA 0.15-0.5mM [U-99% 13C; U-99% 15N] Pdcd4 MA-3 M-C; 25mM sodium phosphate; 100mM sodium chloride; 2.5mM DTT; 2.5mM TCEP; 0.05mM EDTA; 0.2mM AEBSF Protease Inhibitor; 0.02% sodium azide; 95% H2O/5% D2O 95% H2O/5% D2O 150 6.5 ambient 308 6 3D HNCA 0.15-0.5mM [U-99% 13C; U-99% 15N] Pdcd4 MA-3 M-C; 25mM sodium phosphate; 100mM sodium chloride; 2.5mM DTT; 2.5mM TCEP; 0.05mM EDTA; 0.2mM AEBSF Protease Inhibitor; 0.02% sodium azide; 95% H2O/5% D2O 95% H2O/5% D2O 150 6.5 ambient 308 7 3D IPAP TROSY HNCO 0.15-0.5mM [U-99% 13C; U-99% 15N] Pdcd4 MA-3 M-C; 25mM sodium phosphate; 100mM sodium chloride; 2.5mM DTT; 2.5mM TCEP; 0.05mM EDTA; 0.2mM AEBSF Protease Inhibitor; 0.02% sodium azide; 95% H2O/5% D2O 95% H2O/5% D2O 150 6.5 ambient 308 8 3D IPAP TROSY HNCO 0.25mM [U-99% 13C; U-99% 15N] Pdcd4 MA-3 M-C; 25mM sodium phosphate; 100mM sodium chloride; 2.5mM DTT; 2.5mM TCEP; 0.05mM EDTA; 0.2mM AEBSF Protease Inhibitor; 0.02% sodium azide; 10mg/ml Pf1 phage; 95% H2O/5% D2O 95% H2O/5% D2O 150 6.5 ambient 308
NMR Spectrometer Information Spectrometer Manufacturer Model Field Strength 1 Bruker AVANCE 800 2 Bruker DRX 600
NMR Refinement Method Details Software HADDOCK REFINED AS PART OF THE HADDOCK DOCKING PROTOCOL TopSpin
NMR Ensemble Information Conformer Selection Criteria acceptable RMSD to lowest HADDOCK score structure Conformers Calculated Total Number 200 Conformers Submitted Total Number 73 Representative Model 1 (lowest haddock score)
Computation: NMR Software # Classification Version Software Name Author 1 collection TopSpin 2.1 Bruker Biospin 2 processing TopSpin 2.1 Bruker Biospin 3 chemical shift assignment Sparky 3.110 Goddard 4 data analysis Sparky 3.110 Goddard 5 docking HADDOCK 2.0 Cyril Dominguez, Rolf Boelens and Alexandre M.J.J. Bonvin 6 refinement HADDOCK 2.0 Cyril Dominguez, Rolf Boelens and Alexandre M.J.J. Bonvin 7 refinement X-PLOR NIH Schwieters, Kuszewski, Tjandra and Clore